FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)

NARecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 23, 2019

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Cervical Cancer
Interventions
DIAGNOSTIC_TEST

[18-F]- FDG - PET

\[F-18\]-FDG Injection is an intravenous diagnostic radiopharmaceutical used for Positron Emission Tomography. While this is not the subject of investigation in this study, \[F-18\]-FDG will be used in the PET imaging assessment of study participants during their 3 month follow-up post-treatment.

Trial Locations (1)

M5G 2M9

RECRUITING

University Health Network, The Princess Margaret, Toronto

All Listed Sponsors
collaborator

Sunnybrook Health Sciences Centre

OTHER

lead

University Health Network, Toronto

OTHER